Propylthiouracil (PTU) is an antithyroid medication primarily used to manage hyperthyroidism, particularly in patients with Graves' disease. It works by inhibiting the synthesis of thyroid hormones and decreasing the conversion of thyroxine (T4) to triiodothyronine (T3).
